Johnson & Johnson, BMS fight US drug price plan at Third Circuit

16 July 2024 - Pharmaceutical giants Johnson & Johnson, BMS and AstraZeneca are rejecting federal district court decisions that rule ...

Read more →

FTC to sue drug managers over insulin prices

10 July 2024 - Antitrust agency is investigating how PBMs and manufacturers negotiate discounts. ...

Read more →

Pharmacy middlemen appear to be inflating drug prices, FTC says

9 July 2024 - The Federal Trade Commission released a critical report detailing how pharmacy benefit managers—like CVS Health’s Caremark, Cigna’s ...

Read more →

Judge rules against Boehringer Ingelheim in pharma’s latest legal loss on Medicare negotiation

5 July 2024 - A federal judge ruled against Boehringer Ingelheim’s challenge to the new Medicare drug price negotiation program, ...

Read more →

President Biden: Novo Nordisk, Eli Lilly must stop ripping off Americans with high drug prices

2 July 2024 - If Novo Nordisk and other pharmaceutical companies refuse to substantially lower prescription drug prices in our country ...

Read more →

HHS announces cost savings for 64 prescription drugs thanks to the Medicare Rebate Program established by the Biden-Harris Administration’s Lower Cost Prescription Drug Law

26 June 2024 - Under President Biden’s Inflation Reduction Act, some people with Medicare will pay less for some Part ...

Read more →

The opaque industry secretly inflating prices for prescription drugs

21 June 2024 - Pharmacy benefit managers are driving up drug costs for millions of people, employers and Government. ...

Read more →

ICER publishes protocol for annual assessment of drug coverage policies that present barriers to fair access

5 June 2024 - This year’s analysis will include the top ten commercial formularies by covered lives, and include drugs ...

Read more →

The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study

27 May 2024 - The Patented Medicine Prices Review Board (PMPRB), the agency that regulates the prices of patented medicines in ...

Read more →

PMPRB report examines availability and pricing of new medicines

22 May 2024 - The Patented Medicine Prices Review Board (PMPRB) published the eighth edition of its annual Meds Entry Watch ...

Read more →

'What is the price of comfort?': Oncologist raises concerns about newly approved cancer treatment in Canada

30 April 2024 - A new cancer treatment recently approved in Canada promises to cut treatment time down to just ...

Read more →

J&J, BMS lose challenges to US drug price negotiation program

29 April 2024 - A US judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson ...

Read more →

ICER and NEWDIGS release white paper analysing the challenges and potential policy options for paying for gene therapies

23 April 2024 - Paper outlines policy reforms and market actions to support innovation and access while managing uncertainty, affordability, ...

Read more →

Cost based pricing for innovative medicines Is unviable and harmful

12 April 2024 - Barber et al. just published a fundamentally flawed study on diabetes medicines in JAMA Network Open.  ...

Read more →

Medicare drug price negotiations: policy implications of the first 10 drugs’ features

9 April 2024 - This article describes how CMS’s approach to implementing the negotiations will be shaped by the distinctive ...

Read more →